NEW YORK, May 31, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Global Sleep Apnea Diagnostic And Therapeutic Devices
Industry
http://www.reportlinker.com/p098389/Global-Sleep-Apnea-Diagnostic-And-Therapeutic-Devices-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Respiratory_Devices
This report analyzes the worldwide markets for Sleep Apnea
Diagnostic and Therapeutic Devices in US$ Million by the following
Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG,
& Others (include Screening Devices)), and Therapeutic Devices
(CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and
Humidifiers)). The report provides separate comprehensive analytics
for the US, Japan, Europe, and Rest of World. Annual estimates and
forecasts are provided for the period 2007 through 2015. A
seven-year historic analysis is also provided for these markets.
The report profiles 57 companies including many key and niche
players worldwide such as Astro-Med Inc., Grass Technologies,
Cadwell Laboratories, Inc., CareFusion Corporation, Compumedics
Ltd., DeVilbiss Healthcare, Embla Systems, evo Medical Solutions,
Inc., Fisher & Paykel Healthcare Limited, Itamar Medical Ltd.,
Invacare Corporation, Natus Medical Inc., Bio-Logic, Stellate
Systems, Inc., Philips Healthcare, ResMed Inc., Teleflex Medical,
Vital Signs Inc., and Weinmann Geräte für Medizin
GmbH+CCo. KG. Market data and analytics are derived from primary
and secondary research. Company profiles are mostly ex
‘/>”/>
SOURCE